These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26656145)

  • 1. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
    Kamstrup PR; Nordestgaard BG
    JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
    Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
    Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
    JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study.
    Kamstrup PR; Nordestgaard BG
    Lancet Diabetes Endocrinol; 2013 Nov; 1(3):220-7. PubMed ID: 24622370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
    Kamstrup PR; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
    Circulation; 2008 Jan; 117(2):176-84. PubMed ID: 18086931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
    Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
    Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort.
    Arsenault BJ; Boekholdt SM; Dubé MP; Rhéaume E; Wareham NJ; Khaw KT; Sandhu MS; Tardif JC
    Circ Cardiovasc Genet; 2014 Jun; 7(3):304-10. PubMed ID: 24704946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence.
    Nielsen MB; Çolak Y; Benn M; Mason A; Burgess S; Nordestgaard BG
    Cardiovasc Res; 2024 Feb; 120(1):95-107. PubMed ID: 37897683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.
    Chen HY; Dufresne L; Burr H; Ambikkumar A; Yasui N; Luk K; Ranatunga DK; Whitmer RA; Lathrop M; Engert JC; Thanassoulis G
    JAMA Cardiol; 2018 Jan; 3(1):18-23. PubMed ID: 29128868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis.
    Kritharides L; Nordestgaard BG; Tybjærg-Hansen A; Kamstrup PR; Afzal S
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3390-3399. PubMed ID: 28651346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
    Langsted A; Nordestgaard BG; Kamstrup PR
    J Am Coll Cardiol; 2019 Jul; 74(1):54-66. PubMed ID: 31272552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
    Dalila N; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    Atherosclerosis; 2023 Jul; 376():26-33. PubMed ID: 37263031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
    Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
    Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
    Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study.
    Kaltoft M; Sigvardsen PE; Afzal S; Langsted A; Fuchs A; Kühl JT; Køber L; Kamstrup PR; Kofoed KF; Nordestgaard BG
    Atherosclerosis; 2022 May; 349():166-174. PubMed ID: 34903381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.